Literature DB >> 18773064

Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma?

E Buc1, M Lesurtel, J Belghiti.   

Abstract

Major surgical resection is often the only curative treatment for cholangiocarcinoma. When imaging techniques fail to establish the accurate diagnosis, biopsy of the lesion is unavoidable. However, biopsy is not necessarily required for topography of the cholangiocarcinoma (intrahepatic or extrahepatic). 1) In extrahepatic cholangiocarcinoma (ECC), clinical features and radiological imaging relate to biliary obstruction. Provided that between 8% and 43% of bile duct strictures are not ECC, the lesions mimicking ECC that should be ruled out are gallbladder cancer, Mirizzi syndrome, primary sclerosing cholangitis (PSC), autoimmune pancreatitis and portal biliopathy. Systematic biopsy is usually difficult and has poor sensitivity, but a good knowledge of these mimicking ECC diseases, along with precise analysis of clinical and imaging semiology, may lead to a correct diagnosis without the need for biopsy. 2) Intrahepatic cholangiocarcinoma (ICC) developing in normal liver appears as a hypovascular tumour with fibrotic component and capsular retraction that can be confused with fibrous metastases such as breast and colorectal cancers. The lack of the primary site, a relatively large tumour size and ancillary findings such as bile duct dilatation may provide a clue to the diagnosis. If not, we advocate local resection with lymph node dissection, since ICC is the most likely diagnosis and surgery is the only curative treatment. In the event of adenocarcinoma from unknown primary, surgery is an effective treatment even if prognosis is poor.

Entities:  

Year:  2008        PMID: 18773064      PMCID: PMC2504385          DOI: 10.1080/13651820802014585

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  90 in total

Review 1.  Imaging of intrahepatic and hilar cholangiocarcinoma.

Authors:  B I Choi; J M Lee; J K Han
Journal:  Abdom Imaging       Date:  2004-06-08

2.  An increasing incidence of cholangiocarcinoma: why?

Authors:  Laurie Blendis; Zamir Halpern
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

3.  Metastatic cancer of the liver resulting in obstruction of the extrahepatic bile duct.

Authors:  H Takasan; O Kitamura; K Ozawa; I Honjo
Journal:  Am J Surg       Date:  1973-06       Impact factor: 2.565

4.  Differential diagnosis of stenosing lesions at the hepatic hilus.

Authors:  Jonathan Koea; Andrew Holden; Kai Chau; John McCall
Journal:  World J Surg       Date:  2004-04-19       Impact factor: 3.352

5.  Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.

Authors:  T Hasebe; M Sakamoto; K Mukai; N Kawano; M Konishi; M Ryu; S Fukamachi; S Hirohashi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 6.  Lymphoplasmacytic sclerosing pancreatitis (autoimmune pancreatitis): evaluation with multidetector CT.

Authors:  Satomi Kawamoto; Stanley S Siegelman; Ralph H Hruban; Elliot K Fishman
Journal:  Radiographics       Date:  2008 Jan-Feb       Impact factor: 5.333

7.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

8.  Elevation of serum IgG4 in Western patients with autoimmune sclerosing pancreatocholangitis: a word of caution.

Authors:  Steven N Hochwald; Alan W Hemming; Peter Draganov; Stephen B Vogel; Lisa R Dixon; Stephen R Grobmyer
Journal:  Ann Surg Oncol       Date:  2008-01-26       Impact factor: 5.344

9.  Endoscopic retrograde wire-guided cytology of malignant biliary strictures using a novel scraping brush.

Authors:  V K Parasher; K Huibregtse
Journal:  Gastrointest Endosc       Date:  1998-09       Impact factor: 9.427

10.  Implications of peritoneal cytology for staging of early pancreatic cancer.

Authors:  A L Warshaw
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

View more
  5 in total

1.  Fascioliasis simulating an intrahepatic cholangiocarcinoma-Case report with imaging and pathology correlation.

Authors:  Héctor Losada; Michael Hirsch; Pablo Guzmán; Flery Fonseca; Edmundo Hofmann; Martín Alanís
Journal:  Hepatobiliary Surg Nutr       Date:  2015-02       Impact factor: 7.293

2.  Outcome of surgical resection in Klatskin tumors.

Authors:  Alejandro Serrablo; Luis Tejedor
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

3.  A pancreatic mass and extreme elevation of CA 19-9: a benign masquerade of cholangiocarcinoma.

Authors:  Catherine Hall; Mairi McLaren; Charles Mosse
Journal:  J Surg Case Rep       Date:  2022-02-16

4.  The Preoperative Assessment of Hepatic Tumours: Evaluation of UK Regional Multidisciplinary Team Performance.

Authors:  M G Wiggans; S A Jackson; B M T Fox; J D Mitchell; S Aroori; M J Bowles; E M Armstrong; J F Shirley; D A Stell
Journal:  HPB Surg       Date:  2013-08-22

Review 5.  Approach to Solid Liver Masses in the Cirrhotic Patient.

Authors:  Nimer Assy; Najib Assy; Nir Samuel; Aracdi Lerman; William Nseir
Journal:  Gastroenterology Res       Date:  2009-09-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.